Table 4 Medications used for continuous prophylactic treatment by patients with HAE-nlC1-INH
From: Abstracts of 11th C1-inhibitor Deficiency & Angioedema Workshop
|  | TOTAL (66/143 = 46.1%) | HAE – F12 (53/116 = 45.7%) | HAE – UNKNOWN (12/25 = 48%) | Angiopoetin 1 (1/2 = 50%) | ||||
|---|---|---|---|---|---|---|---|---|
n = 66 | % | n = 53 | % | n = 12 | % | n = 1 | % | |
Tranexamic acid | 52 | 78.8 | 43 | 81.1 | 8 | 66.7 | 1 | 100 |
Danazol | 20 | 30.3 | 12 | 22.6 | 7 | 58.3 | 1 | 100 |
Oxandrolone | 14 | 21.2 | 8 | 15.1 | 5 | 41.7 | 1 | 100 |
Epsilon aminocaproic acid | 4 | 6.1 | 0 | Â | 3 | 25 | 1 | 100 |